Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -84.83x is 23% below its 3-year average of -68.77x, near the high end of its 3-year range (-453.20x–-20.69x).
As of the fiscal period ended Sunday, December 31, 2023. 49.41% above its 12-month average of -167.69x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -84.83x.
INTEREST COVERAGE RATIO
-84.83x
INTEREST COVERAGE RATIO AVG TTM
-167.69x
INTEREST COVERAGE RATIO AVG 3Y
-68.77x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+49.41%
CURRENT VS 3Y AVG
-23.36%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.45x
median of 522 covered companies
CURRENT VS SECTOR MEDIAN
-1215.18%
vs the sector median at left
Nexalin Technology, Inc.
Market Cap
$3.51M
Interest Coverage Ratio
-84.83x
TTM Avg
-167.69x
3Y Avg
-68.77x
5Y Avg
N/A
Market Cap
$3.53M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49M
Interest Coverage Ratio
N/A
TTM Avg
3249.00x
3Y Avg
3249.00x
5Y Avg
3249.00x
Market Cap
$3.46M
Interest Coverage Ratio
-0.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.63M
Interest Coverage Ratio
-345.15x
TTM Avg
1.19x
3Y Avg
1.19x
5Y Avg
1.19x
Market Cap
$3.27M
Interest Coverage Ratio
-507.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.25M
Interest Coverage Ratio
-12.86x
TTM Avg
85.32x
3Y Avg
145.98x
5Y Avg
123.76x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | $3.51M | -84.83x | -167.69x | -68.77x | N/A |
| Eocene Ltd. (EOCN)vs › | $3.52M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A | 3249.00x | 3249.00x | 3249.00x |
| Moolec Science S.A. (MLEC)vs › | $3.46M | -0.25x | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.63M | -345.15x | 1.19x | 1.19x | 1.19x |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -507.49x | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -12.86x | 85.32x | 145.98x | 123.76x |
| Evogene Ltd. (EVGN)vs › | $3.79M | -7.42x | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.16M | -12.83x | N/A | N/A | N/A |
Interest Coverage
-84.8x
Debt/Equity
0.00
Current Ratio
1.25
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -84.83x |
| 2023-09-30 | -453.20x |
| 2023-06-30 | -158.91x |
| 2023-03-31 | -88.20x |
| 2022-12-31 | -53.32x |
| 2022-09-30 | -28.05x |
| 2022-06-30 | -25.73x |
| 2022-03-31 | -20.69x |
| 2021-12-31 | -31.32x |
| 2021-09-30 | -66.07x |
| 2021-06-30 | -115.80x |
| 2021-03-31 | -83.51x |
